Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peterfy

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
Arthritis and Rheumatism|February 1, 2011
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agentsMark C Genovese, Arthur Kavanaugh, Michael E Weinblatt, et al.
Seminars in Arthritis and Rheumatism|February 19, 2013
Proceedings from the 5th Annual International Society for Musculoskeletal Imaging in Rheumatology Annual ConferencePhilip G Conaghan, Mikkel Ostergaard, Maria Antonietta D'Agostino, et al.
The Lancet. Rheumatology|January 26, 2024
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot studyMark C Genovese, Norman B Gaylis, David Sikes, et al.
Radiology|December 1, 1995
Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement ratesP Lang, G Honda, T Roberts, et al.
The Journal of Rheumatology|May 3, 2014
Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trialJoel M Kremer, Charles Peterfy, Anthony S Russell, et al.
Annals of the Rheumatic Diseases|October 21, 2011
Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGEPaul P Tak, William Rigby, Andrea Rubbert-Roth, et al.
Annals of the Rheumatic Diseases|August 1, 2019
Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient responseRoy M Fleischmann, Mark C Genovese, Jeffrey V Enejosa, et al.
RMD Open|May 28, 2024
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE studyRoy Fleischmann, Jerzy Swierkot, Sara K Penn, et al.
Osteoarthritis and Cartilage|May 23, 2006
The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritisL Torres, D D Dunlop, C Peterfy, et al.
Magnetic Resonance Imaging|May 4, 2004
Multispectral analysis of bone lesions in the hands of patients with rheumatoid arthritisRichard A D Carano, John A Lynch, Janos Redei, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
Arthritis and Rheumatism|February 1, 2011
An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agentsMark C Genovese, Arthur Kavanaugh, Michael E Weinblatt, et al.
Seminars in Arthritis and Rheumatism|February 19, 2013
Proceedings from the 5th Annual International Society for Musculoskeletal Imaging in Rheumatology Annual ConferencePhilip G Conaghan, Mikkel Ostergaard, Maria Antonietta D'Agostino, et al.
The Lancet. Rheumatology|January 26, 2024
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot studyMark C Genovese, Norman B Gaylis, David Sikes, et al.
Radiology|December 1, 1995
Musculoskeletal neoplasm: perineoplastic edema versus tumor on dynamic postcontrast MR images with spatial mapping of instantaneous enhancement ratesP Lang, G Honda, T Roberts, et al.
The Journal of Rheumatology|May 3, 2014
Longterm safety, efficacy, and inhibition of structural damage progression over 5 years of treatment with abatacept in patients with rheumatoid arthritis in the abatacept in inadequate responders to methotrexate trialJoel M Kremer, Charles Peterfy, Anthony S Russell, et al.
Annals of the Rheumatic Diseases|October 21, 2011
Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGEPaul P Tak, William Rigby, Andrea Rubbert-Roth, et al.
Annals of the Rheumatic Diseases|August 1, 2019
Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient responseRoy M Fleischmann, Mark C Genovese, Jeffrey V Enejosa, et al.
RMD Open|May 28, 2024
Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE studyRoy Fleischmann, Jerzy Swierkot, Sara K Penn, et al.
Osteoarthritis and Cartilage|May 23, 2006
The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritisL Torres, D D Dunlop, C Peterfy, et al.
Magnetic Resonance Imaging|May 4, 2004
Multispectral analysis of bone lesions in the hands of patients with rheumatoid arthritisRichard A D Carano, John A Lynch, Janos Redei, et al.
Pageof 19